These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19523469)

  • 1. ErbB signaling is required for the proliferative actions of GLP-2 in the murine gut.
    Yusta B; Holland D; Koehler JA; Maziarz M; Estall JL; Higgins R; Drucker DJ
    Gastroenterology; 2009 Sep; 137(3):986-96. PubMed ID: 19523469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ErbB activity links the glucagon-like peptide-2 receptor to refeeding-induced adaptation in the murine small bowel.
    Bahrami J; Yusta B; Drucker DJ
    Gastroenterology; 2010 Jun; 138(7):2447-56. PubMed ID: 20226187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.
    Dubé PE; Forse CL; Bahrami J; Brubaker PL
    Gastroenterology; 2006 Aug; 131(2):589-605. PubMed ID: 16890611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "cryptic" mechanism of action of glucagon-like peptide-2.
    Rowland KJ; Brubaker PL
    Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G1-8. PubMed ID: 21527727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion.
    Rowland KJ; Trivedi S; Lee D; Wan K; Kulkarni RN; Holzenberger M; Brubaker PL
    Gastroenterology; 2011 Dec; 141(6):2166-2175.e7. PubMed ID: 21925122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice.
    Yusta B; Holland D; Waschek JA; Drucker DJ
    Endocrinology; 2012 Jun; 153(6):2623-32. PubMed ID: 22535770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators.
    Dubé PE; Brubaker PL
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E460-5. PubMed ID: 17652153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts.
    Bulut K; Pennartz C; Felderbauer P; Meier JJ; Banasch M; Bulut D; Schmitz F; Schmidt WE; Hoffmann P
    Eur J Pharmacol; 2008 Jan; 578(2-3):279-85. PubMed ID: 17920582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2.
    Ivory CP; Wallace LE; McCafferty DM; Sigalet DL
    Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1202-10. PubMed ID: 18845573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of phosphatidylinositol-3 kinase-gamma in the actions of glucagon-like peptide-2 on the murine small intestine.
    Anini Y; Izzo A; Oudit GY; Backx PH; Brubaker PL
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1599-606. PubMed ID: 17284578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis.
    von Lindern M; Deiner EM; Dolznig H; Parren-Van Amelsvoort M; Hayman MJ; Mullner EW; Beug H
    Oncogene; 2001 Jun; 20(28):3651-64. PubMed ID: 11439328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-induced proliferation of bladder cancer cells is mediated through activation of the epidermal growth factor system.
    Ornskov D; Nexo E; Sorensen BS
    FEBS J; 2006 Dec; 273(23):5479-89. PubMed ID: 17116246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection.
    Kaji T; Tanaka H; Redstone H; Wallace LE; Holst JJ; Sigalet DL
    J Surg Res; 2009 Apr; 152(2):271-80. PubMed ID: 19062041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: glucagon-like peptide 2--current applications and future directions.
    Wallis K; Walters JR; Forbes A
    Aliment Pharmacol Ther; 2007 Feb; 25(4):365-72. PubMed ID: 17217448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of glial cell-line derived neurotropic factor family receptor alpha2 in the actions of the glucagon-like peptides on the murine intestine.
    McDonagh SC; Lee J; Izzo A; Brubaker PL
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G461-8. PubMed ID: 17585017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor signaling mediated by grb2 associated binder1 is required for the spatiotemporally regulated proliferation of olig2-expressing progenitors in the embryonic spinal cord.
    Hayakawa-Yano Y; Nishida K; Fukami S; Gotoh Y; Hirano T; Nakagawa T; Shimazaki T; Okano H
    Stem Cells; 2007 Jun; 25(6):1410-22. PubMed ID: 17332510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells.
    Koehler JA; Harper W; Barnard M; Yusta B; Drucker DJ
    Cancer Res; 2008 Oct; 68(19):7897-904. PubMed ID: 18829546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14.
    Klinger S; Poussin C; Debril MB; Dolci W; Halban PA; Thorens B
    Diabetes; 2008 Mar; 57(3):584-93. PubMed ID: 18025410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.